作者: S. MIYAKIS , M. D. LOCKSHIN , T. ATSUMI , D. W. BRANCH , R. L. BREY
DOI: 10.1111/J.1538-7836.2006.01753.X
关键词:
摘要: New clinical, laboratory and experimental insights, since the 1999 publication of Sapporo preliminary classification criteria for antiphospholipid syndrome (APS), had been addressed at a workshop in Sydney, Australia, before Eleventh International Congress on antibodies. In this document, we appraise existing evidence clinical features APS during forum. Based this, propose amendments to criteria. We also provide definitions that were not included updated